Fig. 10

Evaluation results based on the utility modelling for patients starting at EDSS 4. Within each panel, the alternatives’ preference rates are shown at varying levels of the minimum utility difference. Distributions over the risk intervals for serious adverse effects are varied column-wise, with risks generally decreasing to the right (see main text). The proportion of risk attributed to the background for serious adverse effects is increased by row downwards. As an example, the preference rates presented in Fig. 9 are found in the second row and the second column, at the minimum utility difference 0.4